arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Arcus Biosciences, Inc.

RCUS

$28.70 ▲ +0.30 (+1.06%) at close

11 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Arcus Biosciences, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.1B

Dividend Yield —

Revenue Growth -4.3% ↘

Op. Margin -156.3% ↘

ROIC -52.9% ↗

FCF / Share $-4.51 ↘

Trailing P/E —

Price / Book 5.7x

FCF Yield —

Debt / Equity 0.16

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$247.00M

↓ -4.3% —

Net Income Profit after all expenses

$-353.00M

↓ -24.7% —

Operating Margin Operating profit as % of sales

-156.3%

↓ -22.2% 1th

FCF / Share Free cash flow per share

$-4.51

↓ -130.7% —

Long-Term Debt Long-term obligations

$99.00M

↑ +106.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	-4.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-153%)	120.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1406%)	4.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-44%)	-70.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-984%)	394.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4826%)	416.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5110%)	79.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+895%)	491.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6039%)	—	—	—
EPS Growth YoY (%)	-4.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	24.3% Good Good Year-over-year change in earnings per share Optimal: > 10%	-11.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	-24.7% Weak ↓ Weak Declining Year-over-year change in net income	7.8% Fair Fair Year-over-year change in net income	-15.0% Weak Weak Year-over-year change in net income	N/M	N/M	-45.0% Weak ↑ Weak Improving Year-over-year change in net income	-70.8% Weak ↑ Weak Improving Year-over-year change in net income	6.6% Fair Fair Year-over-year change in net income	-195.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-130.7% Weak Weak Year-over-year change in free cash flow	56.2% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	N/M	N/M	-29.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	83.7% Excellent Excellent Year-over-year change in free cash flow	-55.8% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	30.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-12.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	14.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	95.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	257.9% Excellent Excellent Compound annual revenue growth over 3 years	280.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	26.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	76.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	69.5% Excellent Excellent Compound annual revenue growth over 5 years	139.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	-156.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1142%)	-127.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-953%)	-290.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2037%)	-250.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1767%)	14.1% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6%)	-160.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1168%)	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	-142.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1291%)	-109.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1014%)	-262.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2287%)	-238.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2087%)	13.8% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+15%)	-158.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1421%)	—	—	—	—	—
FCF Margin (%) (%)	-196.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-68.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-282.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	385.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-73.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	139.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-1.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-5.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.88x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-52.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.2% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	58.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	71.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-28.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-55.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-473%)	-58.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-489%)	-66.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-543%)	-40.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	6.3% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-58%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-51.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	73.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+389%)	89.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+499%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-42.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	-165.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-123.00M	$-102.00M	$-127.00M	$-206.00M	$-148.00M	$-173.41M	$-57.94M	$-71.06M	$-98.43M	$-65.16M	$-46.87M
Debt / EBITDA (x)	-0.26x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$2.30	$2.86	$1.58	$1.56	$5.53	$1.41	$0.33	$0.23	$0.36	—	—
Basic EPS, GAAP (USD)	$-3.29	$-3.14	$-4.15	$-3.71	$0.76	$-2.24	—	—	—	—	—
Free Cash Flow per Share (USD)	$-4.51	$-1.95	$-4.46	$6.00	$-4.07	$1.97	$-1.66	$-1.29	$-7.87	$-5.05	—
Book Value per Share (USD)	$5.04	$5.26	$6.12	$9.01	$11.89	$7.71	$3.57	$5.28	$-17.68	$-5.92	—
Tangible Book Value per Share (USD)	$5.04	$5.26	$6.12	$9.01	$11.89	$7.71	$3.57	$5.28	$-17.68	$-5.92	—
Basic Weighted Avg Shares (shares)	107.40M	90.10M	74.00M	72.00M	69.30M	54.79M	45.39M	36.36M	3.89M	3.37M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$776.00M	$790.00M	$647.00M	$874.00M	$1.10B	$614.15M	$170.00M	$242.01M	$164.14M	—	—
LT Debt (USD)	$99.00M	$48.00M	$0.00	—	—	—	—	—	—	—	—
Total Equity (USD)	$631.00M	$485.00M	$462.00M	$657.00M	$842.00M	$502.30M	$163.84M	$234.94M	$-72.33M	$-19.99M	$-2.17M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$247.00M	$258.00M	$117.00M	$112.00M	$383.00M	$77.52M	$15.00M	$8.35M	$1.41M	—	—
Net Income, GAAP (USD)	$-353.00M	$-283.00M	$-307.00M	$-267.00M	$53.00M	$-122.86M	$-84.71M	$-49.59M	$-53.08M	$-17.97M	—
Operating Cash Flow (USD)	$-482.00M	$-170.00M	$-306.00M	$438.00M	$-256.00M	$111.17M	$-73.46M	$-43.00M	$-25.06M	$-12.94M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 39 quarters

Arcus Biosciences, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RCUS with peers